5Enomoto T,Fujita M,Inoue M,et al.Alterations of the P53 tumer suppressorgene and its association with activation of the C-K-ras-2 proto oncogen in thepremalignant and malignant lesions of the human uterine endometrium.CancerRes,1993,53:1883.
6Kohler MF,Berchuck A,Davidoff AM,et al.Overexpression and mutation of P53in endometrial carcinoma.Cancer Res,1992,52:1662.
7Bur ME,Perlman C,Edelman L,et al.P53 expression in neoplasms of the uterinecorpus.Am J Clin Pathol,1992,98:81
8Fontanini G,Bigini D,Vignati S,et al.P53expression in nonsmall cell lungcancer:clinical and biologic correlation.Anticancer Res,1993,13:737
6Jianing Liu1, Gaofeng Bi1, Pei’e Wen1, Weihua Yang1, Xia Ren1, Tianhua Tang1, Chao Xie1, Wei Dong1 and Guosheng Jiang1, 21Department of Hemato-oncology, Institute of Basic Medicine, Shandong Academy of Medical Sciences,Key Laboratory for Modern Medicine and Technology of Shandong Province,Key Medical Laboratory for Tumor Immunology & Traditional Chinese Medicine Immunology of Shandong Province, Jinan, Shandong 250062, China.Down-Regulation of CD44 Contributes to the Differentiation of HL-60 Cells Induced by ATRA or HMBA[J].Cellular & Molecular Immunology,2007,4(1):59-63. 被引量：13
